Insider trade

Officer sold ~$376K of DGX shares in the open market

Traded Jul 28, 2026 · Filed Jul 29, 2026

~$376K
Reported value · 1,600 sh @ $235.18: 10K
Holds after · shares reported: −1.6%
stock since the trade · S&P 500 +4.6%, $235.94 → $232.22 on Oct 5

Why it stands out

Quest Diagnostics's SVP & Chief Commercial Officer sold $376K of Quest Diagnostics shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jul 28, 2026
Reporting period: Not applicable
Filed with the SEC: Jul 29, 2026

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$376,288

Shares × reported transaction price

Timing vs results

5 days after results of Jul 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $235.94 on Jul 28, 2026, at its 52-week high, after a 16% rise over the previous 30 trading days

52-week range $167.41 (Jul 31, 2025) to $235.94 (Jul 28, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $203.06 on Jun 12, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+1.8%	+3.6%	−1.8%
30 days	+2.6%	+3.4%	−0.9%

Past results only. Not a forecast.

Source receipt

Record ID: 0001022079-26-000087
Filed / recorded: Jul 29, 2026, 9:04 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: QUEST DIAGNOSTICS INC
Issuer CIK: 1022079
Ticker: DGX
Reporting person: Mark E Delaney
Relationship: Officer
Officer title: SVP & Chief Commercial Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jul 28, 2026
Transaction code: S
Shares / units: 1,600
Price per share: $235.18
Acquired / disposed: Disposed (D)
Shares owned after: 10,335
Ownership form: Direct
Amendment: No

Footnotes from the filing

This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Around the same time

5%+ stake

4.9%Stake

8w ago

The holder reported owning less than 5%, which ends its duty to keep reporting this stake.

More Official record

Fund moves

3,756Shares reported · +285 vs prior quarter

8w ago

From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.

More Official record

Carol D. Miller soldSits on House Ways and Means, Health

$15,001–$50,000Reported range · official band, not an exact amount

8w ago

2 different filers disclosed DGX within 90 days. Disclosed 521 days after the transaction; reported as an official range, not an exact amount.

More Official record